| Literature DB >> 28915407 |
Saowanee Jiwlawat1, Eileen Lynch1, Jennifer Glaser1, Ivy Smit-Oistad1, Jeremy Jeffrey1, Jonathan M Van Dyke1, Masatoshi Suzuki2.
Abstract
Human induced-pluripotent stem cells (iPSCs) are a promising resource for propagation of myogenic progenitors. Our group recently reported a unique protocol for the derivation of myogenic progenitors directly (without genetic modification) from human pluripotent cells using free-floating spherical culture. Here we expand our previous efforts and attempt to determine how differentiation duration, culture surface coatings, and nutrient supplements in the medium influence progenitor differentiation and formation of skeletal myotubes containing sarcomeric structures. A long differentiation period (over 6 weeks) promoted the differentiation of iPSC-derived myogenic progenitors and subsequent myotube formation. These iPSC-derived myotubes contained representative sarcomeric structures, consisting of organized myosin and actin filaments, and could spontaneously contract. We also found that a bioengineering approach using three-dimensional (3D) artificial muscle constructs could facilitate the formation of elongated myotubes. Lastly, we determined how culture surface coating matrices and different supplements would influence terminal differentiation. While both Matrigel and laminin coatings showed comparable effects on muscle differentiation, B27 serum-free supplement in the differentiation medium significantly enhanced myogenesis compared to horse serum. Our findings support the possibility to create an in vitro model of contractile sarcomeric myofibrils for disease modeling and drug screening to study neuromuscular diseases.Entities:
Keywords: Human pluripotent stem cells; Induced pluripotent stem cells; Muscle differentiation; Neuromuscular diseases; Sarcomere; Skeletal muscle
Mesh:
Year: 2017 PMID: 28915407 PMCID: PMC5669825 DOI: 10.1016/j.diff.2017.07.004
Source DB: PubMed Journal: Differentiation ISSN: 0301-4681 Impact factor: 3.880